Zynext Ventures is investing in Illexcor Therapeutics to advance the clinical development of ILX002, its lead candidate for ...

The project is expected to get underway in March 2025. Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company ...

Zydus Lifesciences has introduced VaxiFlu-4, India's first quadrivalent influenza vaccine to combat flu season. This new vaccine provides broader protection by covering both influenza A and B ...